Tim joined Orphalan in 2021. He has over twenty-five years’ experience leading international multi-disciplined matrix teams within pharma and academia. Tim has lead R&D teams progressing assets in multiple therapeutic areas, including hepatology, chronic pain, asthma, oncology and anti-infectives, through all phases of preclinical and clinical development, generating multiple marketed products. Prior to joining Orphalan, Tim was Head of Clinical Development at Mundipharma. Previously he held an academic position at the National Institutes of Health, Bethesda, USA and senior R&D positions within Pfizer, Eisai, Takeda, and PrEP Biopharm.
Tim has a BSc and PhD in Biochemistry from the University of Bath.